Dmitry Anatolevich Tatarinov

A new strategy for effective antidotes against organophosphorus compounds (OPs) is enzyme-loaded nanoscavenger technology. Cell membrane-coated nanoforms of bioscavengers reduce adverse effects and ensure stability, immunotolerance, and prolonged protective action. For the first time, synthesis of double layers polymersomes coated by red blood cells (erythrocytes) ghosts, based on amphiphilic di- and triblock polyethylene glycol–polysulfide copolymers (PEG-b-PPS) was carried out to make enzyme microreactors. The enzyme was an evolved multiple mutant of the archaea Saccharolobus solfataricus phosphotriesterase (PTE). Two approaches were used for making this formulation: lipid fusion and hypotonic swelling. Respectively two types of PTE-loaded nanoscavengers (i) hybrid camouflaging RBC–PTE–loaded polymersomes and (ii) PTE–polymersomes captured by erythrocytes ghosts (PTE–RBC–microreactors) were prepared with high encapsulation efficiency, loading capacity and enzyme activity. CD-1 mice were challenged with paraoxon as a model OP. Pre-treatment of animals with i.v. injected PTE–RBC–microreactors led to LD₅₀ shifts up to 15.5 times compared to control mice. In post-exposure treatments, LD₅₀ shifts were up to 9.8 times. Pharmacokinetics of PTE–RBC–microreactors showed half times of 20 min and 1 hour for distribution and elimination phases, respectively. These first results with erythrocyte ghost microreactors are promising and open a new way to personalized medical countermeasures for detoxification of OPs and other toxicants.

A new approach was proposed for the synthesis of the 3H-benzo[d][1,2]oxaphospholes ethyl esters by the three-component acid-catalyzed reaction of triethylphosphite with carbonyl compounds and phenols. It allows obtaining target structures in one synthetic step from available reagents. Trifluoromethanesulfonic acid was shown to be an effective catalyst for the process.

Novel 1-phenyl(1-thiophen-2-yl)-4-(diphenylphosphoryl)butane-1,3-diones were synthesized by the Claisen-type condensation of 1-(diphenylphosphoryl)propan-2-one with ethyl phenyl(thiophene-2-yl)carboxylates. The tautomeric equilibrium of diketone moiety of phosphine oxides was investigated by ¹H and ¹³C{¹H} NMR spectroscopy. Two species out of five possible tautomers (diketo and mono-enol) were observed in the solution of 1-phenyl(1-thiophen-2-yl)-4-(diphenylphosphoryl)butane-1,3-diones. The major tautomer was the mono-enol form with content 80–90%. Furthermore, the double bond position at C³ atom was determined by ¹³C{¹H} NMR spectroscopy.

Novel 4-(diphenylphosphoryl)-1-phenylbutane-1,3-dione was synthesized by the reaction of diketone enamine with diphenylchloro phosphine followed by oxidation and hydrolysis of the enamine phosphine formed. Tautomeric transformation of the diketone moiety of phosphine oxide was investigated by ¹H NMR. Three out of five possible tautomers were observed in the 4-(diphenylphosphoryl)-1-phenylbutane-1,3-dione solution. The major tautomer was the form with a diketone fragment.

The divergent synthesis of benzo[e]-1,2-oxaphosphinines or benzo[d]-1,2-oxaphospholenes along with spirocyclic quasiphosphonium compounds based on 2-alkenylphenols and phosphorus(III/V) chlorides is presented. The reaction is condition-dependent and determined by the biphility of the phosphorus(III) derivative and the dual reactivity of 2-alkenylphenol. The procedures are applicable for obtaining benzo[e]-1,2-oxaphosphinines substituted at position 4 and disubstituted at positions 4 and 5 as well as 3,3-disubstituted benzo[d]-1,2-oxaphospholenes with good to high yields.

Encapsulated phosphotriesterase nanoreactors show their efficacy in the prophylaxis and post-exposure treatment of poisoning by paraoxon. A new enzyme nanoreactor (E-nRs) containing an evolved multiple mutant (L72C/Y97F/Y99F/W263V/I280T) of Saccharolobus solfataricus phosphotriesterase (PTE) for in vivo detoxification of organophosphorous compounds (OP) was made. A comparison of nanoreactors made of three- and di-block copolymers was carried out. Two types of morphology nanoreactors made of di-block copolymers were prepared and characterized as spherical micelles and polymersomes with sizes of 40 nm and 100 nm, respectively. The polymer concentrations were varied from 0.1 to 0.5% (w/w) and enzyme concentrations were varied from 2.5 to 12.5 μM. In vivo experiments using E-nRs of diameter 106 nm, polydispersity 0.17, zeta-potential −8.3 mV, and loading capacity 15% showed that the detoxification efficacy against paraoxon was improved: the LD₅₀ shift was 23.7xLD₅₀ for prophylaxis and 8xLD₅₀ for post-exposure treatment without behavioral alteration or functional physiological changes up to one month after injection. The pharmacokinetic profiles of i.v.-injected E-nRs made of three- and di-block copolymers were similar to the profiles of the injected free enzyme, suggesting partial enzyme encapsulation. Indeed, ELISA and Western blot analyses showed that animals developed an immune response against the enzyme. However, animals that received several injections did not develop iatrogenic symptoms.

The present work demonstrates the optimization of the ligand structure in the series of bis(phosphine oxide) and β-ketophosphine oxide representatives for efficient coordination of Tb³⁺ and Eu³⁺ ions with the formation of the complexes exhibiting high Tb³⁺- and Eu³⁺-centered luminescence. The analysis of the stoichiometry and structure of the lanthanide complexes obtained using the XRD method reveals the great impact of the bridging group nature between two phosphine oxide moieties on the coordination mode of the ligands with Tb³⁺ and Eu³⁺ ions. The bridging imido-group facilitates the deprotonation of the imido- bis(phosphine oxide) ligand followed by the formation of tris-complexes. The spectral and PXRD analysis of the separated colloids indicates that the high stability of the tris-complexes provides their safe conversion into polystyrenesulfonate-stabilized colloids using the solvent exchange method. The red Eu³⁺-centered luminescence of the tris-complex exhibits the same specificity in the solutions and the colloids. The pronounced luminescent response on the antibiotic ceftriaxone allows for sensing the latter in aqueous solutions with an LOD value equal to 0.974 μM.

The present work demonstrates the optimization of the ligand structure in the series of bis-phosphine oxide and carbamoylphosphine oxide representatives for efficient coordination of Tb3+ and Eu3+ ions with the formation of the complexes exhibiting high Tb3+- and Eu3+-centered luminescence. The analysis of the stoichiometry and structure of the lanthanide complexes obtained by XRD method reveals the great impact of the bridging group nature between two phosphine oxide moieties on the coordination mode of the ligands with Tb3+ and Eu3+ ions. The bridging imido-group facilitates the deprotonation of imido-bisphosphine oxide ligand followed by the formation of tris-complexes. The spectral and PXRD analysis of the separated colloids indicates that the high stability of the tris-complexes provides their safe conversion into polystyrenesulfonate-stabilized colloids under the solvent exchange method. The red Eu3+-centered luminescence of the tris-complex exhibits the same specificity in the solutions and the colloids. The pronounced luminescent response on the antibiotics ceftriaxone allows to sense the latter in aqueous solutions with the LOD value equal to 0.974 M.